Join us at this year's EANM 27th Annual Congress. We look forward to engaging with the delegates of this meeting and learning the latest in nuclear medicine and molecular imaging. We are excited to be exhibiting at booth #H04.C.


Check out this Top Rated Oral Presentation, featuring our lead investigational imaging agent, Zr89 Zirconium 89, titled "Dose Rates and Patient Contact Restrictions Following Zirconium-89 (Zr89) Positron Emisson Tomography (PET) Studies" on Monday, October 21, 2024 in Hall Y1-Y3 from 15:00 - 16:00.

Click here for a copy of our conference leaflet.

Learn more about our lead investigational imaging agent, CD8 ImmunoPET™ and radiopharmaceutical therapies by connecting with us by submitting a meeting request.

EANM24 logo green 1

ImaginAb staff who attended the event

Gareth Smith

VP, Business Strategy

William Le

VP, Global Operations

Kristin Schmiedehausen

VP, Medical Affairs

Michael Ferris

Associate Director, Operations

Ollie Brown

Radiopharmaceutical Supply Chain Manager

back to News and Events